Bristol-Myers Squibb Co
XMUN:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
Industria de Diseno Textil SA
F:IXD2
|
ES |
|
A
|
APTIV PLC
F:D7A
|
CH |
|
SBM Offshore NV
OTC:SBFFF
|
NL |
|
K
|
Kumba Iron Ore Ltd
SWB:KUI
|
ZA |
|
C
|
Chilwa Minerals Ltd
ASX:CHW
|
AU |
|
C
|
Ciena Corp
LSE:0HYA
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
|
H World Group Ltd
F:CL4
|
CN |
|
G
|
General Dynamics Corp
XHAM:GDX
|
US |
|
B
|
BlackRock Inc
F:UU2
|
US |
|
Arista Networks Inc
F:1170
|
US |
|
N
|
Netcare Ltd
JSE:NTC
|
ZA |
|
H
|
Hasbro Inc
XMUN:HAS
|
US |
|
Ameriprise Financial Inc
NYSE:AMP
|
US |
|
A
|
Anheuser-Busch Inbev SA
VSE:ABIN
|
BE |
|
L
|
Legrand SA
XMUN:LRC
|
FR |
|
Clariane SE
F:KO2
|
FR |
|
C
|
Corning Inc
XMUN:GLW
|
US |
|
L
|
L'Oreal SA
F:LOR
|
FR |
|
A
|
Allegion PLC
F:60A
|
IE |
|
D
|
Darden Restaurants Inc
F:DDN
|
US |
|
A
|
Agilent Technologies Inc
XMUN:AG8
|
US |
|
A
|
Abercrombie & Fitch Co
F:AFT
|
US |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 60.32 EUR with a low forecast of 35.14 EUR and a high forecast of 73.06 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
60.32
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 60.32 EUR with a low forecast of 35.14 EUR and a high forecast of 73.06 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is -2%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -2%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 7%.